Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Placental plasminogen activator inhibitor 1 is induced by platelet-derived TGF-β independently of TGF-β receptor 3 and is upregulated in preeclampsia.

Molecular human reproduction·2026
Same author

Effect of green mediterranean diet on serum folate and its interaction with genetic variation in folate metabolism: The DIRECT PLUS 18-month dietary randomized controlled trial.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health: MRI-Assessed 5- and 10-Year Follow-Up After 2 Clinical Trials.

Circulation·2026
Same author

Endothelial dysfunction and metabolic biomarkers in post-COVID-19 syndrome.

Scientific reports·2026
Same author

Obesity-Related Coagulation Activation in Adolescents and Children: A Systematic Review and Meta-Analysis.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026
Same author

Sustained visceral fat loss is associated with attenuated brain atrophy and improved cognitive function in late midlife.

Nature communications·2026

Related Experiment Video

Updated: May 23, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Human RAGE antibody protects against AGE-mediated podocyte dysfunction.

Sandra Müller-Krebs1, Lars P Kihm, Thati Madhusudhan

  • 1Department of Nephrology, University of Heidelberg, Heidelberg, Germany. sandra.mueller@urz.uni-heidelberg.de

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|April 19, 2012
PubMed
Summary

Human RAGE antibody (hRAGEab) protects against kidney damage in peritoneal dialysis (PD) patients. Blocking advanced glycation end-products (AGE) and glucose degradation products (GDP) interaction with RAGE preserves podocyte function and residual renal function (RRF).

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Related Experiment Videos

Last Updated: May 23, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Area of Science:

  • Nephrology
  • Cell Biology
  • Biochemistry

Background:

  • Residual renal function (RRF) is crucial for patient survival in peritoneal dialysis (PD).
  • Glucose degradation products (GDP) and advanced glycation end-products (AGE) in PD fluid (PDF) can cause local and systemic damage, leading to RRF loss.
  • Podocytes are key structures in the kidney filtration barrier, and their damage contributes to RRF decline.

Purpose of the Study:

  • To investigate the impact of GDP and AGE on human podocyte structure and function.
  • To determine if human RAGE antibody (hRAGEab) can prevent AGE/RAGE interaction and subsequent podocyte damage.
  • To explore the potential of hRAGEab in preserving RRF in PD patients.

Main Methods:

  • Human podocytes were incubated with or without hRAGEab, followed by exposure to control solution, PDF, or GDP.
  • Podocyte damage was assessed using immunofluorescence, western blot, ELISA, and migration assays.
  • Key markers of podocyte damage, inflammation (NF-κB, IL-6), AGE expression, and apoptosis were quantified.

Main Results:

  • hRAGEab significantly reduced podocyte damage induced by PDF and GDP.
  • AGE expression and inflammation markers (NF-κB, IL-6) were decreased in the presence of hRAGEab.
  • hRAGEab preserved podocyte actin cytoskeleton organization, synaptopodin expression, and motility, while reducing apoptosis.

Conclusions:

  • GDP-containing PDF contributes to RRF loss in PD patients.
  • hRAGEab offers protection against PDF- and GDP-induced podocyte dysfunction by blocking AGE/RAGE interaction.
  • Targeting the AGE/RAGE pathway with hRAGEab may be a therapeutic strategy to preserve RRF in PD.